Cyndya Shibao, M.D

Measurement of Splanchnic venous capacitance(SVC)done at Baseline and after 90 min of 75 g glucose in Healthy Controls POTS patients

To measure levels of circulating monocyte/ T cell doublets after 28 days of 2 HOBA treatment

Blood laboratory Testing

Levels of inflammatory cytokine ( IL-6) in post-COVID-19 POTS and controls

not_applicable

To Measure levels of circulating monocyte/ T cell doublets at Baseline

To Measure Orthostatic Tachycardia after 28 days of Treatment with 2HOBA

To Measure Splanchnic venous capacitance after 28 days of Treatment with 2HOBA

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

+10 more interventions

18 unique interventions3 categories

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting2

Other2

Role Distribution

Principal Investigator4

PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT07189936Phase 2Recruiting

Long COVID19Post-Acute COVID-19 SyndromePostural Tachycardia Syndrome (POTS)+1 more

PrincipalinvestigatorStart date: 2025-12-18

NCT05375968Phase 2Recruiting

Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

Postural Tachycardia Syndrome (POTS)

PrincipalinvestigatorStart date: 2023-02-25

NCT05421208Not ApplicableActive Not Recruiting

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

Long COVIDPost-acute COVID-19 SyndromePostural Tachycardia Syndrome (POTS)+1 more

PrincipalinvestigatorStart date: 2022-06-01

NCT05344599Active Not Recruiting

Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

Acute Hepatic PorphyriaPostural Orthostatic Tachycardia Syndrome

PrincipalinvestigatorStart date: 2022-01-19

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Postural Tachycardia Syndrome (POTS)3 Post-Acute COVID-19 Syndrome2 COVID-192 Acute Hepatic Porphyria1 Long Covid-191 Postural Orthostatic Tachycardia Syndrome1

Affiliations

Vanderbilt University Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Avindra Nath, M.D.

National Institute of Neurological Disorders and Stroke (NINDS)

14 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeCOVID-19

Similarity Score10%

Xiaolong Qi, MD

LanZhou University

8 trials

Shared therapeutic areas:

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

Toshimitsu Tokimoto

Astrazeneca KK

16 trials

Shared therapeutic areas:

Wenhong Zhang, MD

Huashan Hospital

4 trials

Shared therapeutic areas:

Mitchell S Cairo, MD

New York Medical College

13 trials

Shared therapeutic areas:

Mohamed mamdouh Elsayed, MD

Lecturer

11 trials

Shared therapeutic areas:

Post-Acute COVID-19 Syndrome

Marie Carmen Valenza, phD

Universidad de Granada

25 trials

Shared therapeutic areas:

Melissa Stockwell, MD MPH

Columbia University

14 trials

Shared therapeutic areas:

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

15 trials

Shared therapeutic areas: